Refine by
Eluting Stent Suppliers & Manufacturers
26 companies found
based inWinsen, GERMANY
Stron Medical was launched in 2010 as a product line of QualiMed. With an impressive range of innovative products and a committed team of sales professionals, Stron Medical provides end-to-end solutions within Germany. QualiMed was found in 1997 as ...
The GALAXY Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) ...
based inMiami Lakes, FLORIDA (USA)
Cordis is an independent, customer-focused provider of interventional cardiovascular technologies. During our 60-year history we’ve established a legacy of pioneering breakthrough technologies, including the first guiding catheters and coronary drug ...
based inBirmingham, ALASKA (USA)
Endomimetics has developed a BioNanomatrix that can be used to coat these devices and mimic human tissue which minimizes the need for additional surgeries, improves the longevity of the device, reduces complications associated with having foreign ...
In many medical settings, devices are commonly used to help doctors treat patients. For example, stents are often used to open blocked arteries, repair torn vessels, and even to keep nasal passages from swelling shut after surgery. Unfortunately ...
based inVienna, AUSTRIA
P+F Products + Features GmbH is a medical technology company focused on research, development, and manufacture of innovative minimally invasive solutions in the field of cardiology. Our R&D capabilities are the foundation of our approach to ...
The EFIL+ Sirolimus Eluting Stent System is a combination product comprised of two regulated components: a device (a coronary stent system) and a drug product (a formulation of Sirolimus contained ...
based inZibo, CHINA
Bluesail Medical Co., Ltd. (Bluesail Medical) was founded in 2002 and is a leading medical device enterprise with the complete layout of low, medium and high value consumables. The company’s four major sectors are: i) Healthcare Protective Business ...
EXCEL is the first biodegradable polymer sirolimus eluting stent (BP-SES), being widely used in percutaneous coronary intervention (PCI) for patients with coronary atherosclerotic disease. A large number of ...
based inEden Prairie, MINNESOTA (USA)
Surmodics’ leadership in surface technologies dates to our development of the drug-delivery coating for the first drug-eluting stent. Since then, we’ve consistently pioneered breakthrough lubricious, hemocompatible, and drug-delivery COATINGS for ...
based inTel Aviv, ISRAEL
Medinol is dedicated to the science of cardiovascular intervention. For over 20 years, we have delivered over two million coronary stents to patients worldwide. Medinol is dedicated to the science of cardiovascular intervention. For over 20 years, ...
Ridaforolimus Eluting Coronary Stent System; Excellent clinical outcomes. Redefining deliverability with a new spring tip. Low footprint cobalt-chromium design. Optimal conformability and vessel support. Elastomeric ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
Unmatched XLIMUS clinical performance. The ultimate DES for complex artery lesions. XLIMUS is considered as the ultimate coronary DES stent system to treat complex coronary artery disease by reaching and crossing the most challenging ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
Arterius has developed a polymer-based bioresorbable scaffold (or “BRS”) ArterioSorb™ that is intended to: Match the ease of delivery of Bare Metal Stent (BMS) and Drug Eluting ...
based inWinsen, GERMANY
QualiMed was found in 1997 as an OEM manufacturer for implantable medical devices with a focus on the development and regulatory approval of coronary stents and their respective delivery devices. Later the business was expanded to peripheral ...
The MAGMA Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) ...
based inCarpinteria, CALIFORNIA (USA)
Our comprehensive technical capabilities range from the design and manufacture of minimally invasive, catheter, and handheld technology to the development and production of medical components utilizing advanced materials and processes. We lead the ...
A variety of specialized materials are being used in today’s MedTech environment. Many of these materials are only made suitable for the intended finished use by applying a customized surface treatment. These treatments can result in reduced ...
based inShanghai, CHINA
MicroPort is a global medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and healthier lives. All our solutions are designed to deliver on that belief. Our close ...
TARGET All Comers Trial: 1,656 Patients from 20 sites in Europe. 1:1 RCT Real World open-label, non-inferiority trial Primary endpoint: TLF @12 months. Confirms that the Firehawk®, a low dose sirolimus eluting biodegradable polymer DES, is safe. ...
based inSant Vicenç dels Horts, SPAIN
We design, develop, manufacture and assemble components, semi-finished products, and final devices for Interventional Radiology and Cardiology using proprietary know-how and technologies. Founded and based in Barcelona by a team of more than 60 ...
We manufacture DES Drug Delivery with proprietary delivery systems. We handle several drugs and have shown controlled release over a prolonged period enabling healing of the surrounding vascular tissue and endothelial layer. ...
based inMilpitas, CALIFORNIA (USA)
Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Since 2005, the company has continually sought to improve the treatment of vascular disease with: Drug-eluting coronary stent systems ...
The DESyne X2 Novolimus Eluting Coronary Stent System is a low-profile DES with high flexibility and exceptional deliverability. The ultra-thin design of its stent and polymer coating, with no ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
based inMumbai, INDIA
Established in 2009, Veritas Bioventions Pvt Ltd is a Medical Devices Company, specialized in development of innovative products aimed at improving the quality of human life. We have state of art manufacturing facilities designed with scientific ...
A new dimension of Hybrid Stent design – Greater flexibility and trackability. 65u stent strut thickness – Great scaffolding and visibility under fluoroscopy. ...
based inRanga Reddy, INDIA
Relisys Medical Devices Limited is one of the world’s leading manufacturer of cardiovascular medical devices including Coronary Stents Systems - both Bare Metal Stent Systems & Drug Eluting Stent Systems, PTCA Balloons Catheters, Angiographic ...
Highlighting Features: • Pristine+ elutes Everolimus drug which is the most preferred drug by most of the interventional cardiologists • The basic stent platform for Pristine+ is L605 Cobalt Chromium ...
based inHorsham, UNITED KINGDOM
Veryan has developed innovative technology to improve the performance of vascular stents by adopting the principle of biomimicry; developing structures that imitate those occurring naturally. Veryan’s vascular biomimetic stent technology involves ...
The Challenge: Peripheral Arterial Disease. People are living longer and with an increase in the incidence of obesity, diabetes and other contributing factors, claudication may cause substantial tissue changes and, in some scenarios, can lead to ...
based inTampa, FLORIDA (USA)
Concept Medical is driving innovation in medical devices, with a focus on developing technologies for drug delivery with a strong emphasis on intellectual property. Based in Tampa, Florida; Concept Medical has always striven to find solutions to ...
ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease. ABLUMINUS DES+ Receives on-label ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Umirolimus, a macrocyclic triene lactone Rapamycin derivative, is powerful immunosuppressant and anti-inflammatory agent. Umirolimus has highly lipophilicity and can be used agent-eluting stent (DES) ...